← Open Payments lookup

PRABJEET KAUR: Open Payments

NPI 1881469179 · RIVERDALE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,636 in 59 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $854 · 2025 $1,636

Food & beverage: $1,636
CompanyPaymentsAmount
GENZYME CORPORATION17$503
AstraZeneca Pharmaceuticals LP7$410
Novartis Pharmaceuticals Corporation8$147
GlaxoSmithKline, LLC.6$98
Galderma Laboratories, L.P.1$95
Lilly USA, LLC4$89
Invivyd Inc3$49
Takeda Pharmaceuticals U.S.A., Inc.2$37
Regeneron Healthcare Solutions, Inc.2$37
Cycle Pharmaceuticals Inc2$34

Products named: DUPIXENT, TEZSPIRE, Rhapsido, NEMLUVIO, EBGLYSS, NUCALA, PEMGARDA, HYQVIA.

Industry payments across NJ — which companies pay providers there.